Bringing Medicines for HIV Prevention to a Family Planning Clinic
Women and Infants Hospital of Rhode Island · with Advance RI CTR · NCT06930508
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- $25“Patient participants will receive a $25 gift card for completing the post-intervention survey.”
- Who can join
- Ages 16+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 83
- US sites recruiting
- 1
- Study start
- May 28, 2026
- Record last updated
- August 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are:
- Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic?
- What things make it easier or harder to ask about PrEP in a family planning clinic setting?
- What things make it easier or harder to begin PrEP in a family planning clinic setting?
Patient participants
- Will receive standardized counseling about PrEP.
- Will have the opportunity to begin PrEP as part of their routine, ongoing care.
- Will be asked to complete a survey about their experiences.
Physician participants
- Will receive standardized education about PrEP.
- Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP.
- Will be asked to complete pre-and post-study surveys about their experiences.
- May be asked to complete a post-study in-depth interview about their experiences.
Being studied: Patient participant screening; Physician participant training
Conditions: HIV; PrEP
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
This study will include patient participants who:
- Are age 16 or older
- Are presenting for care at the Women and Infants Hospital of Rhode Island Family Planning Clinic
- Speak English or Spanish
- Have decisional capacity
This study will exclude patient participants who:
- Are currently seeking abortion care
This study will include physician participants who:
- Provide care at the Women and Infants Hospital of Rhode Island Family Planning Clinic
This study will not have any specific exclusion criteria for physician participants.
Recruiting US locations
Women and Infants Hospital of Rhode Island
Providence, RI 02905
Site contact: Benjamin P Brown, MD, MS · 401-274-1122 · benjamin_brown@brown.edu
Study contacts (from the official record)
- Benjamin P Brown, MD, MS · 401-274-1122 · benjamin_brown@brown.edu
- Erica J Hardy, MD, MMSc, MA · 401-453-7950 · erica_hardy@brown.edu
Similar studies in Rhode Island
All healthy volunteers studies in Rhode Island →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Providence, RI + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- East Greenwich, RI + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- East Greenwich, RI + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Brown University
- Location
- Providence, RI
- Eligibility basics
- Ages 18+